Category: Guest content

Biotechnology Management Papers

These papers are from the 2009 final projects in the NIH Foundation for Advanced Education in the Sciences TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons biotechnology company management: Financial opportunities for early stage biotech companies Tamara Jones The […]




Click here for reuse options!
Copyright 2009 Biotechblog

The changing roles of CRO

This is a student paper from the 2009 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons on biotechnology company management. The changing roles of CRO Alex Bao […]




Click here for reuse options!
Copyright 2009 Biotechblog

Discovering potential drug targets

This is a student paper from the 2009 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons on biotechnology company management. Discovering potential drug targets Myung K. Kim […]




Click here for reuse options!
Copyright 2009 Biotechblog

Financial opportunities for early stage biotech companies

This is a student paper from the 2009 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons on biotechnology company management. Financial opportunities for early stage biotech companies […]




Click here for reuse options!
Copyright 2009 Biotechblog

Solving the FDA Crisis

Guest content from John Avellanet, managing director and principal of Cerulean Associates: Solving the FDA Crisis By John Avellanet, Managing Director and Principal of Cerulean Associates LLC News of the latest crisis under the FDA’s watch – salmonella contamination and the peanut plant in Georgia – has all the usual suspects calling for increased inspections […]




Click here for reuse options!
Copyright 2009 Biotechblog

The Critical Reasons You Need to Plan Your Business, then Work Your Plan

Guest content from Sandy Graham, managing partner at Sequoyah Associates: A Business Plan is the single most important document you will develop in establishing and growing your business. How your business plan is developed is certainly up to you. Either you can take the time to develop your plan, or you can work with one […]




Click here for reuse options!
Copyright 2009 Biotechblog

Spread your message with BiotechBlog

Post your content on BiotechBlog and have it syndicated across the web. Send me a pitch using the contact form. Guidelines for submissions are: BiotechBlog focuses on commercial, legal, political, and scientific trends in biotechnology. Your post should fit this framework. Posts should be action-oriented (case studies, best practices, guidelines, etc.) or otherwise insightful (perspectives, backgrounders, […]




Click here for reuse options!
Copyright 2008 Biotechblog

Intellectual Property Theft on the Rise

Guest content from John Avellanet, managing director and principal of Cerulean Associates: Intellectual Property Theft on the Rise By John Avellanet, Managing Director and Principal of Cerulean Associates LLC Reprinted with permission from SMARTERCOMPLIANCE™ 2(9): p 1-2 (September 2008) Nine out of ten companies do not have appropriate policies and controls in place to stop […]




Click here for reuse options!
Copyright 2008 Biotechblog

Commercializing biotechnology in China

I recently had the opportunity to conduct a brief interview with Mireille Gingras, Ph.D. President and CEO of HUYA Bioscience on doing business with and in China: Tell me about HUYA and what makes the company unique? HUYA Bioscience International has pioneered the most innovative and productive approach for pharmaceutical co-development between the U.S. and […]




Click here for reuse options!
Copyright 2008 Biotechblog

Contract research helps keep drug pipeline flowing

Guest content from Turner Investment Partners‘ Heather Flick McMeekin, Frank Sustersic, Vijay Shankaran, and Theresa Hoang: Contract research helps keep drug pipeline flowing Imagine a new-product development process that typically lasts 10 to 15 years, has only a one in 5,000 chance of succeeding, and costs at least $800 million. That’s the daunting reality that […]




Click here for reuse options!
Copyright 2008 Biotechblog

%d bloggers like this: